Table 2.

Numbers of tracked MNs to evaluate cell class transitions during kenpaullone treatment (day 0–14)

			Outcome of fate transition				Outcome of fate transition
Conditions	Total tracked # of MNs	Tracked # of Class A MNs	Class A to A	Class A to B	Class A to C	Tracked # of Class B MNs	Class B to A	Class B to B	Class B to C
TF+	86.20 ± 17.08	42.47 ± 13.86	27.47 ± 10.07	0.6000 ± 0.2449	14.40 ± 4.128	43.73 ± 6.322	14.87 ± 4.121	1.733 ± 0.5907	27.13 ± 3.023
TF+/Ken 5uM	80.27 ± 19.01	41.07 ± 15.52	27.60 ± 11.26	0.7333 ± 0.3399	12.73 ± 4.153	39.20 ± 6.538	17.00 ± 4.791	2.333 ± 0.5055	19.87 ± 2.277
TF–/Ken 2.5uM	98.27 ± 21.23	42.80 ± 16.05	21.40 ± 8.362	2.400 ± 0.8781	19.00 ± 7.551	55.47 ± 10.46	15.07 ± 4.993	7.000 ± 1.623	33.40 ± 5.499
TF–/Ken 5uM	96.87 ± 16.16	38.27 ± 11.93	18.67 ± 5.544	1.867 ± 0.7196	17.73 ± 5.743	58.60 ± 12.21	11.80 ± 4.196	7.200 ± 2.560	39.60 ± 7.318
TF–	92.53 ± 19.25	42.47 ± 14.90	11.13 ± 3.868	4.467 ± 1.698	26.87 ± 9.443	50.07 ± 6.998	6.867 ± 1.695	4.333 ± 1.038	38.87 ± 5.904

Data are presented as mean ± SEM (n = 5).